PATIENT ACCESS OPPORTUNITIES AND CHALLENGES FOR BIOSIMILARS- A REVIEW OF THE UNITED STATES MARKETPLACE
Author(s)
Kline SE
Pricing Solutions, Devon, PA, USA
OBJECTIVES: Rising health care budgetary pressures combined with an aging patient population and increasing incidence of chronic diseases provide great opportunities for biosimilars. The 2010 Affordable Care Act includes a Biologics Price Competition and Innovation Act
Conference/Value in Health Info
2017-05, ISPOR 2017, Boston, MA, USA
Value in Health, Vol. 20, No. 5 (May 2017)
Code
PHP281
Topic
Health Policy & Regulatory
Topic Subcategory
Approval & Labeling
Disease
Multiple Diseases
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now